Doug Schenkel
Stock Analyst at Wolfe Research
(2.87)
# 1,571
Out of 5,106 analysts
70
Total ratings
51.92%
Success rate
33.26%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Upgrades: Outperform | $60 | $48.02 | +24.95% | 3 | Dec 10, 2025 | |
| WAT Waters | Upgrades: Outperform | $480 | $383.21 | +25.26% | 2 | Dec 10, 2025 | |
| GH Guardant Health | Upgrades: Outperform | $75 | $102.50 | -26.83% | 3 | Sep 25, 2025 | |
| CAI Caris Life Sciences | Initiates: Outperform | $32 | $28.00 | +14.29% | 1 | Jul 14, 2025 | |
| TEM Tempus AI | Initiates: Outperform | $60 | $64.72 | -7.29% | 1 | Dec 13, 2024 | |
| HOLX Hologic | Initiates: Peer Perform | n/a | $74.87 | - | 5 | Dec 13, 2024 | |
| TWST Twist Bioscience | Initiates: Outperform | $60 | $33.84 | +77.30% | 2 | Dec 13, 2024 | |
| STVN Stevanato Group | Initiates: Outperform | $28 | $20.84 | +34.36% | 1 | Dec 13, 2024 | |
| WST West Pharmaceutical Services | Initiates: Peer Perform | n/a | $277.49 | - | 1 | Dec 13, 2024 | |
| RGEN Repligen | Initiates: Peer Perform | n/a | $166.36 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $3.29 | - | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $285 | $230.83 | +23.47% | 2 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $138.36 | - | 8 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $52 | $45.61 | +12.91% | 2 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $16.50 | - | 3 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $136.19 | - | 5 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $101.59 | - | 4 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $579.94 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.56 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $97.58 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $1.82 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $11.27 | - | 1 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $235.40 | - | 3 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $4.66 | - | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $3.52 | - | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $3.59 | - | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $5.41 | - | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.81 | - | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $21.77 | - | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $18 | $1.65 | +990.91% | 1 | Jun 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $22.62 | - | 2 | Mar 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $80 → $90 | $285.50 | -68.48% | 2 | Feb 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $6.64 | - | 1 | Jan 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $189.44 | - | 1 | Nov 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $16 | $66.86 | -76.07% | 2 | Sep 28, 2017 |
Bruker
Dec 10, 2025
Upgrades: Outperform
Price Target: $60
Current: $48.02
Upside: +24.95%
Waters
Dec 10, 2025
Upgrades: Outperform
Price Target: $480
Current: $383.21
Upside: +25.26%
Guardant Health
Sep 25, 2025
Upgrades: Outperform
Price Target: $75
Current: $102.50
Upside: -26.83%
Caris Life Sciences
Jul 14, 2025
Initiates: Outperform
Price Target: $32
Current: $28.00
Upside: +14.29%
Tempus AI
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $64.72
Upside: -7.29%
Hologic
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $74.87
Upside: -
Twist Bioscience
Dec 13, 2024
Initiates: Outperform
Price Target: $60
Current: $33.84
Upside: +77.30%
Stevanato Group
Dec 13, 2024
Initiates: Outperform
Price Target: $28
Current: $20.84
Upside: +34.36%
West Pharmaceutical Services
Dec 13, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $277.49
Upside: -
Repligen
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $166.36
Upside: -
Nov 14, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $3.29
Upside: -
Oct 31, 2024
Upgrades: Outperform
Price Target: $285
Current: $230.83
Upside: +23.47%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $138.36
Upside: -
Jun 27, 2024
Upgrades: Outperform
Price Target: $52
Current: $45.61
Upside: +12.91%
Jun 27, 2024
Downgrades: Peer Perform
Price Target: n/a
Current: $16.50
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $136.19
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $101.59
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $579.94
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $6.56
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $97.58
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $1.82
Upside: -
Dec 13, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $11.27
Upside: -
Dec 13, 2023
Initiates: Outperform
Price Target: n/a
Current: $235.40
Upside: -
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.66
Upside: -
Aug 16, 2021
Initiates: Market Perform
Price Target: n/a
Current: $3.52
Upside: -
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.59
Upside: -
Jan 12, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.41
Upside: -
Dec 29, 2020
Initiates: Outperform
Price Target: n/a
Current: $1.81
Upside: -
Jul 7, 2020
Initiates: Outperform
Price Target: n/a
Current: $21.77
Upside: -
Jun 19, 2018
Initiates: Outperform
Price Target: $18
Current: $1.65
Upside: +990.91%
Mar 28, 2018
Upgrades: Outperform
Price Target: n/a
Current: $22.62
Upside: -
Feb 22, 2018
Maintains: Outperform
Price Target: $80 → $90
Current: $285.50
Upside: -68.48%
Jan 2, 2018
Initiates: Outperform
Price Target: n/a
Current: $6.64
Upside: -
Nov 1, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $189.44
Upside: -
Sep 28, 2017
Maintains: Outperform
Price Target: $23 → $16
Current: $66.86
Upside: -76.07%